FDA 483 OBSERVATION · #828 OF 1,932 MOST-CITED

Establishment and Implementation of Corrective Action Procedures

FDA cited this observation 23 times across 21 firms in recent inspections. Below: how it breaks down by program area and fiscal year, and real examples of how FDA worded it on Form FDA 483.

What this grouping is not

An observation-type page groups FDA’s published citation records. The grouping, the compliance steps and the root causes are SPEQ synthesis, not an FDA classification of any citation, and a count measures what FDA published rather than risk.

BY PROGRAM AREA
Veterinary Medicine23
BY FISCAL YEAR
FY20265
FY20253
FY20242
FY20225
FY20215
FY20193

How FDA worded it — real examples

You did not implement appropriate written corrective action procedures for preventive controls.

Darling Ingredients, Inc · Coldwater, Michigan · Veterinary Medicine · 2026-05-22

You did not implement appropriate written corrective action procedures for preventive controls.

Ohio Pet Foods, Inc. · Lisbon, Ohio · Veterinary Medicine · 2026-05-21

You did not establish and implement appropriate written corrective action procedures for preventive controls.

Performance Feeds LLC · Caneyville, Kentucky · Veterinary Medicine · 2026-05-05

You did not establish appropriate written corrective action procedures for preventive controls.

Farmina Pet Food USA LLC · Reidsville, North Carolina · Veterinary Medicine · 2026-03-05

You did not implement appropriate written corrective action procedures for preventive controls.

Royal Pet Inc · Hastings, Minnesota · Veterinary Medicine · 2025-10-10

You did not establish and implement appropriate written corrective action procedures for preventive controls.

Best Buy Bones Inc. · Mount Morris, Michigan · Veterinary Medicine · 2025-09-12

Related SPEQ references

Where to read the requirements behind this observation area on SPEQ. These are SPEQ's topic and audience pages — not an FDA classification of the citation.

Quality risk management →Pharmaceutical quality system →Veterinary industry →

Examples are a representative sample of FDA's published inspection observations. Open the 483 observation explorer →